ArticleDie Ophthalmologie2026
[Is less more in individual cases? Minimal treatment for squamous cell carcinoma of the conjunctiva with orbital invasion].
Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 75-year-old female patient presented with a sensation of pressure and a prominence on the right lower eyelid. The computed tomography (CT) of the orbit showed a space-occupying lesion and an anterior transconjunctival orbitotomy with excisional biopsy and cryotherapy of the margins was carried out. The pathological results showed a poorly differentiated nonkeratinizing squamous cell carcinoma (R1). The whole-body staging indicated a primary squamous cell carcinoma of the conjunctiva with orbital invasion of the right eye. The patient refused an orbital exenteration and also adjuvant radiotherapy. Therefore, after a second resection and cryotherapy the patient was treated with a total of 4 cycles of mitomycin C eyedrops due to the residual conjunctival intraepithelial neoplasia (CIN) fragments in the marginal region. This treatment was carried out bilaterally as the contralateral eye showed a CIN grade II. The patient is currently recurrence-free for more than 2 years but the left eye still shows a CIN grade II. In cases of an orbital invasion of a primary squamous cell carcinoma of the conjunctiva treatment with tumor excision, cryotherapy and local chemotherapy can also represent a treatment option.
Indexed as
Identifiers
42295351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.